COVID-19 vaccines reduce the chances of developing severe infection and mortality, ICMR Chief Balram Bhargava said on Tuesday.
Responding to a question about people contracting the coronavirus infection even after taking both doses of COVID vaccine, he said these are "disease-modifying" vaccines and there is an 85 per cent reduction in hospitalisation after vaccination which is well established internationally.
"These vaccines are disease-modifying. After two doses are administered, the antibodies develop. The COVID-19 vaccines reduce the chances of developing severe infection and death due to the disease," the ICMR Director General said.
The Indian Council of Medical Research (ICMR) is the country's top health research body.
Currently, two vaccines -- Covaxin by Bharat Biotech and Oxford-AstraZeneca's Covishield manufactured by Serum Institute of India (SII) -- are being used for inoculation in India.
India's drug regulator has also granted permission for the restricted emergency use of the Russian COVID-19 vaccine Sputnik V with certain conditions.
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled" What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine Found No Proof Of Covid Vaccine Causing Sudden Death, Says Top Medical Body INDIA's "Hit With Footwear" Protest In Mumbai Over Shivaji Statue Collapse Celebrated "Russian Spy" Whale Hvaldimir Found Dead In Norway: Report "It's Mom, I Love You": Mother Of Israeli-American Found Dead In Gaza Video: Vadodara Animal Rescuers Tripling On Scooter - With A Crocodile Ukrainian Drones Target Oil Refinery, Power Plants In Moscow, Says Russia China Woman Fakes Miscarriages, Forges Medical Records To Claim Rs 7.8 Lakh Track Latest News Live on NDTV.com and get news updates from India and around the world.